熱門資訊> 正文
PolyPid任命Nurit Tweezer-Zaks为首席医疗官
2025-08-12 21:05
- PolyPid (NASDAQ:PYPD) announced on Tuesday the appointment of Dr. Nurit Tweezer-Zaks as chief medical officer, effective as of August 18, 2025.
- Tweezer-Zaks, who has served on PolyPid's board of directors, since November 2023, will step down from the Board, effective as of August 17, 2025.
- Prior to joining PolyPid, she served as chief executive officer of MediCane Health.
- PYPD -0.0% premarket to $3.23
- Source: Press Release
More on PolyPid
- Seeking Alpha’s Quant Rating on PolyPid
- Historical earnings data for PolyPid
- Financial information for PolyPid
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。